Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aciclovir 400mg tablets
0503021C0AAACAC
|
Aciclovir (Systemic) | Aciclovir | Infections | 94,651 |
|
Aciclovir 800mg tablets
0503021C0AAADAD
|
Aciclovir (Systemic) | Aciclovir | Infections | 70,598 |
|
Aciclovir 200mg tablets
0503021C0AAABAB
|
Aciclovir (Systemic) | Aciclovir | Infections | 55,058 |
|
Aciclovir 5% cream
1310030C0AAAAAA
|
Aciclovir (Topical) | Aciclovir | Skin | 25,378 |
|
Aciclovir 200mg dispersible tablets
0503021C0AAAGAG
|
Aciclovir (Systemic) | Aciclovir | Infections | 10,178 |
|
Aciclovir 400mg dispersible tablets
0503021C0AAAHAH
|
Aciclovir (Systemic) | Aciclovir | Infections | 8,682 |
|
Aciclovir 800mg dispersible tablets
0503021C0AAAEAE
|
Aciclovir (Systemic) | Aciclovir | Infections | 4,852 |
|
Aciclovir 200mg/5ml oral suspension sugar free
0503021C0AAAAAA
|
Aciclovir (Systemic) | Aciclovir | Infections | 2,183 |
|
Aciclovir 30mg/g eye ointment
1103030C0AAAAAA
|
Aciclovir (Eye) | Aciclovir | Eye | 1,397 |
|
Zovirax 5% cream
1310030C0BBAAAA
|
Zovirax (Topical) | Aciclovir | Skin | 925 |
|
Aciclovir 400mg/5ml oral suspension sugar free
0503021C0AAAFAF
|
Aciclovir (Systemic) | Aciclovir | Infections | 897 |
|
Zovirax Cold Sore 5% cream
1310030C0BBABAA
|
Zovirax (Topical) | Aciclovir | Skin | 132 |
|
Zovirax 200mg dispersible tablets
0503021C0BBAGAG
|
Zovirax (Systemic) | Aciclovir | Infections | 108 |
|
Zovirax 200mg/5ml oral suspension
0503021C0BBABAA
|
Zovirax (Systemic) | Aciclovir | Infections | 70 |
|
Lipsore 5% cream
1310030C0BRAAAA
|
Lipsore | Aciclovir | Skin | 19 |
|
Zovirax 800mg dispersible tablets
0503021C0BBAEAE
|
Zovirax (Systemic) | Aciclovir | Infections | 19 |
|
Zovirax Double Strength 400mg/5ml oral suspension
0503021C0BBAFAF
|
Zovirax (Systemic) | Aciclovir | Infections | 18 |
|
Virasorb Cold Sore 5% cream
1310030C0BFAAAA
|
Virasorb | Aciclovir | Skin | 10 |
|
Zovirax 3% ophthalmic ointment
1103030C0BBAAAA
|
Zovirax (Eye) | Aciclovir | Eye | 5 |
|
Ranovir 400mg tablets
0503021C0BEABAC
|
Ranovir | Aciclovir | Infections | 2 |
|
Cymex Ultra 5% cream
1310030C0BNAAAA
|
Cymex (Aciclovir) | Aciclovir | Skin | 1 |
|
Ranovir 800mg tablets
0503021C0BEACAD
|
Ranovir | Aciclovir | Infections | 1 |
|
Aciclovir 1g/40ml solution for infusion vials
0503021C0AAAKAK
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 250mg/10ml solution for infusion vials
0503021C0AAAIAI
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 500mg/20ml solution for infusion vials
0503021C0AAAJAJ
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.